Lower Estimate for Affymetrix

S&P changes earnings forecasts for Read-Rite and others

Company: Affymetrix (AFFX )

Year ending: Dec-02

Prior estimate: 0.13

New estimate: 0.07

Rationale: Higher than expected costs

Company: CuraGen Corp. (CRGN )

Year ending: Dec-02

Prior estimate: d1.08

New estimate: d1.78

Rationale: Higher R&D and SG&A costs

Company: Read-Rite (RDRT )

Year ending: Sep-02

Prior estimate: 0.15

New estimate: d0.30

Rationale: Prro prod. transition execution

Company: Ultratech Stepper (UTEK )

Year ending: Dec-02

Prior estimate: d0.06

New estimate: 0.10

Rationale: Reflects end-market improvement

Before it's here, it's on the Bloomberg Terminal. LEARN MORE